Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
Radiation-associated sarcomas are rare and aggressive types of sarcomas that can occur after exposure to ionizing radiation. We examine a case of radiation-associated undifferentiated/unclassified soft-tissue sarcoma with primary disease in the chest wall. The optimal treatment of these patients is...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Rare Tumors |
Online Access: | https://doi.org/10.1177/2036361318821763 |
id |
doaj-78f5e7c6d8b54dbcbf707809c94d86ed |
---|---|
record_format |
Article |
spelling |
doaj-78f5e7c6d8b54dbcbf707809c94d86ed2020-11-25T03:38:38ZengSAGE PublishingRare Tumors2036-36132019-01-011110.1177/2036361318821763Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case reportRonak Patel0James Hu1Shefali Chopra2Christopher Lee3Internal Medicine, LAC + USC Medical Center, Glendale, CA, USAMedical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USAPathology, Keck Medical Center, University of Southern California, Los Angeles, CA, USADiagnostic Radiology, Keck Medical Center, University of Southern California, Los Angeles, CA, USARadiation-associated sarcomas are rare and aggressive types of sarcomas that can occur after exposure to ionizing radiation. We examine a case of radiation-associated undifferentiated/unclassified soft-tissue sarcoma with primary disease in the chest wall. The optimal treatment of these patients is surgical resection if possible; however, the role of chemotherapy has not been well defined. The patient described herein had a central tumor in the chest wall. Since many of these patients have borderline resectable tumors, the use of neoadjuvant chemotherapy may be helpful to downstage the tumors for possible surgical resection. In this case, doxorubicin plus ifosfamide chemotherapy was employed with a favorable therapeutic effect prior to being resected. To our knowledge this is the first report of greater than 90% necrosis in a patient with radiation-associated undifferentiated/unclassified soft-tissue sarcoma treated with chemotherapy for a borderline resectable mass.https://doi.org/10.1177/2036361318821763 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ronak Patel James Hu Shefali Chopra Christopher Lee |
spellingShingle |
Ronak Patel James Hu Shefali Chopra Christopher Lee Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report Rare Tumors |
author_facet |
Ronak Patel James Hu Shefali Chopra Christopher Lee |
author_sort |
Ronak Patel |
title |
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report |
title_short |
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report |
title_full |
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report |
title_fullStr |
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report |
title_full_unstemmed |
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report |
title_sort |
neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: a case report |
publisher |
SAGE Publishing |
series |
Rare Tumors |
issn |
2036-3613 |
publishDate |
2019-01-01 |
description |
Radiation-associated sarcomas are rare and aggressive types of sarcomas that can occur after exposure to ionizing radiation. We examine a case of radiation-associated undifferentiated/unclassified soft-tissue sarcoma with primary disease in the chest wall. The optimal treatment of these patients is surgical resection if possible; however, the role of chemotherapy has not been well defined. The patient described herein had a central tumor in the chest wall. Since many of these patients have borderline resectable tumors, the use of neoadjuvant chemotherapy may be helpful to downstage the tumors for possible surgical resection. In this case, doxorubicin plus ifosfamide chemotherapy was employed with a favorable therapeutic effect prior to being resected. To our knowledge this is the first report of greater than 90% necrosis in a patient with radiation-associated undifferentiated/unclassified soft-tissue sarcoma treated with chemotherapy for a borderline resectable mass. |
url |
https://doi.org/10.1177/2036361318821763 |
work_keys_str_mv |
AT ronakpatel neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport AT jameshu neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport AT shefalichopra neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport AT christopherlee neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport |
_version_ |
1724541411945086976 |